Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis
Author(s) -
Winston E. Abara,
Philip R. Spradling,
Yuping Zhong,
Anne C. Moorman,
Eyasu H. Teshale,
Loralee B. Rupp,
Stuart C. Gordon,
Mark A. Schmidt,
Joseph A. Boscarino,
Yihe G. Daida,
Scott D. Holmberg
Publication year - 2019
Publication title -
journal of gastrointestinal cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.473
H-Index - 47
eISSN - 1941-6628
pISSN - 1941-6636
DOI - 10.1007/s12029-019-00255-4
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , cohort , gastroenterology , hepatitis c virus , hepatitis c , hepatitis b virus , medical record , logistic regression , virus , immunology
Six-monthly hepatocellular carcinoma (HCC) screening in cirrhotic patients has been recommended since 2011. HCC prognosis is associated with diagnosis at an early stage. We examined the prevalence and correlates of 6-monthly HCC surveillance in a cohort of HCV-infected cirrhotic patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom